Table of Contents
Journal of Signal Transduction
Volume 2012 (2012), Article ID 376470, 10 pages
http://dx.doi.org/10.1155/2012/376470
Research Article

A Bioinformatics Resource for TWEAK-Fn14 Signaling Pathway

1Institute of Bioinformatics, International Tech Park, Bangalore 560066, India
2Amrita School of Biotechnology, Amrita University, Kollam 690525, India
3Department of Biotechnology, Kuvempu University, Shankaraghatta 577451, India
4Department of Biochemistry and Molecular Biology, Pondicherry University, Puducherry 605014, India
5Centre of Excellence in Bioinformatics, School of Life Sciences, Pondicherry University, Puducherry 605014, India
6Bone Cell Biology Group, Discipline of Orthopaedics and Trauma, University of Adelaide and The Hanson Institute, Adelaide, 5002 SA, Australia
7McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
8Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
9Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
10Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA

Received 22 December 2011; Accepted 3 February 2012

Academic Editor: A. Yoshimura

Copyright © 2012 Mitali Bhattacharjee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Chicheportiche, P. R. Bourdon, H. Xu et al., “TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis,” Journal of Biological Chemistry, vol. 272, no. 51, pp. 32401–32410, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Novoyatleva, F. Diehl, M. J. Van Amerongen et al., “TWEAK is a positive regulator of cardiomyocyte proliferation,” Cardiovascular Research, vol. 85, no. 4, pp. 681–690, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. S. P. Fortin, M. J. Ennis, B. A. Savitch et al., “Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function,” Molecular Cancer Research, vol. 7, no. 11, pp. 1871–1881, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. N. L. Tran, W. S. McDonough, P. J. Donohue et al., “The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors,” American Journal of Pathology, vol. 162, no. 4, pp. 1313–1321, 2003. View at Google Scholar · View at Scopus
  5. A. Ortiz, M. D. Sanchez-Nino, M. C. Izquierdo et al., “TWEAK and the kidney: the dual role of a multifunctional cytokine,” Advances in Experimental Medicine and Biology, vol. 691, pp. 323–335, 2011. View at Publisher · View at Google Scholar
  6. V. Pelekanou, G. Notas, K. Theodoropoulou et al., “Detection of the TNFSF members BAFF, APRIL, TWEAK and their receptors in normal kidney and renal cell carcinomas,” Analytical Cellular Pathology, vol. 34, no. 1-2, pp. 49–60, 2011. View at Publisher · View at Google Scholar
  7. N. G. Kataria, M. M. Bartold, A. A. S. K. Dharmapatni, G. J. Atkins, C. A. Holding, and D. R. Haynes, “Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis,” Journal of Periodontal Research, vol. 45, no. 4, pp. 564–573, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. C. N. Lynch, Y. C. Wang, J. K. Lund, Y. W. Chen, J. A. Leal, and S. R. Wiley, “TWEAK induces angiogenesis and proliferation of endothelial cells,” Journal of Biological Chemistry, vol. 274, no. 13, pp. 8455–8459, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Kawashima, Y. I. Kawamura, T. Oshio et al., “Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis,” Gastroenterology, vol. 141, no. 6, pp. 2119–2129, 2011. View at Publisher · View at Google Scholar
  10. M. Petitbarat, M. Rahmati, V. Sérazin et al., “Tweak appears as a modulator of endometrial il-18 related cytotoxic activity of uterine natural killers,” PLoS ONE, vol. 6, no. 1, Article ID e14497, 2011. View at Publisher · View at Google Scholar
  11. A. Ikner and A. Ashkenazi, “TWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated Death Domain (FADD), and caspase-8,” Journal of Biological Chemistry, vol. 286, no. 24, pp. 21546–21554, 2011. View at Publisher · View at Google Scholar
  12. S. R. Wiley and J. A. Winkles, “TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor,” Cytokine and Growth Factor Reviews, vol. 14, no. 3-4, pp. 241–249, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Jakubowski, C. Ambrose, M. Parr et al., “TWEAK induces liver progenitor cell proliferation,” Journal of Clinical Investigation, vol. 115, no. 9, pp. 2330–2340, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Vincent, D. M. Findlay, K. J. Welldon et al., “Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFα induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts,” Journal of Bone and Mineral Research, vol. 24, no. 8, pp. 1434–1449, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Desplat-Jego, S. Varriale, R. Creidy et al., “TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity,” Journal of Neuroimmunology, vol. 133, no. 1-2, pp. 116–123, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Kamijo, A. Nakajima, K. Kamata, H. Kurosawa, H. Yagita, and K. Okumura, “Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA,” Rheumatology, vol. 47, no. 4, pp. 442–450, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. H. X. Gao, S. R. Campbell, L. C. Burkly et al., “TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells,” Cytokine, vol. 46, no. 1, pp. 24–35, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. A. B. Sanz, M. D. Sanchez-Niño, M. C. Izquierdo et al., “TWEAK activates the non-canonical NFkappaB pathway in murine renal tubular cells: modulation of CCL21,” PloS one, vol. 5, no. 1, p. e8955, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Girgenrath, S. Weng, C. A. Kostek et al., “TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration,” EMBO Journal, vol. 25, no. 24, pp. 5826–5839, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. T. C. Polek, M. Talpaz, B. G. Darnay, and T. Spivak-Kroizman, “TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor,” Journal of Biological Chemistry, vol. 278, no. 34, pp. 32317–32323, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. A. A.S.S.K. Dharmapatni, M. D. Smith, T. N. Crotti et al., “TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis,” Arthritis Research and Therapy, vol. 13, no. 2, p. R51, 2011. View at Publisher · View at Google Scholar
  22. N. L. Tran, W. S. McDonough, B. A. Savitch, T. F. Sawyer, J. A. Winkles, and M. E. Berens, “The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFκB pathway activation and BCL-XL/BCL-W expression,” Journal of Biological Chemistry, vol. 280, no. 5, pp. 3483–3492, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Jakubowski, B. Browning, M. Lukashev et al., “Dual role for TWEAK in angiogenic regulation,” Journal of Cell Science, vol. 115, no. 2, pp. 267–274, 2002. View at Google Scholar · View at Scopus
  24. D. Wang, J. N. T. Fung, Y. Tuo, L. Hu, and C. Chen, “TWEAK/Fn14 promotes apoptosis of human endometrial cancer cells via caspase pathway,” Cancer Letters, vol. 294, no. 1, pp. 91–100, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. J. Kaplan, E. E. Lewis, E. A. Shelden et al., “The apoptotic ligands TRAIL, TWEAK, and fas ligand mediate monocyte death induced by autologous lupus T cells,” Journal of Immunology, vol. 169, no. 10, pp. 6020–6029, 2002. View at Google Scholar · View at Scopus
  26. M. Nakayama, N. Kayagaki, N. Yamaguchi, K. Okumura, and H. Yagita, “Involvement of TWEAK in interferon γ-stimulated monocyte cytotoxicity,” Journal of Experimental Medicine, vol. 192, no. 9, pp. 1373–1379, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. J. E. Vince, D. Chau, B. Callus et al., “TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFα,” Journal of Cell Biology, vol. 182, no. 1, pp. 171–184, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Kaptein, M. Jansen, G. Dilaver et al., “Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3),” FEBS Letters, vol. 485, no. 2-3, pp. 135–141, 2000. View at Google Scholar · View at Scopus
  29. P. Schneider, R. Schwenzer, E. Haas et al., “TWEAK can induce cell death via endogenous TNF and TNF receptor 1,” European Journal of Immunology, vol. 29, no. 6, pp. 1785–1792, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. J. A. Moreno, B. Munoz-Garcia, J. L. Martín-Ventura et al., “The CD163-expressing macrophages recognize and internalize TWEAK. Potential consequences in atherosclerosis,” Atherosclerosis, vol. 207, no. 1, pp. 103–110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. S. A. N. Brown, H. N. Hanscom, H. Vu, S. A. Brew, and J. A. Winkles, “TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules,” Biochemical Journal, vol. 397, no. 2, pp. 297–304, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. R. L. Meighan-Mantha, D. K. W. Hsu, Y. Guo et al., “The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration,” Journal of Biological Chemistry, vol. 274, no. 46, pp. 33166–33176, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. S. A. N. Brown, C. M. Richards, H. N. Hanscom, S. L. Y. Feng, and J. A. Winkles, “The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-κB activation,” Biochemical Journal, vol. 371, no. 2, pp. 395–403, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Chorianopoulos, T. Heger, M. Lutz et al., “FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK,” Basic Research in Cardiology, vol. 105, no. 2, pp. 301–313, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Mustonen, H. Säkkinen, H. Tokola et al., “Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats,” Acta Physiologica, vol. 199, no. 1, pp. 11–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. J. M. Weinberg, “TWEAK-Fn14 as a mediator of acute kidney injury,” Kidney International, vol. 79, no. 2, pp. 151–153, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Xu, A. Okamoto, J. Ichikawa et al., “TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF,” Biochemical and Biophysical Research Communications, vol. 318, no. 2, pp. 422–427, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. J. A. Winkles, “The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting,” Nature Reviews Drug Discovery, vol. 7, no. 5, pp. 411–425, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. J. A. Winkles, N. L. Tran, S. A. Brown, N. Stains, H. E. Cunliffe, and M. E. Berens, “Role of TWEAK and Fn14 in tumor biology,” Frontiers in Bioscience, vol. 12, pp. 2761–2771, 2007. View at Google Scholar · View at Scopus
  40. S. A. N. Brown, A. Ghosh, and J. A. Winkles, “Full-length, membrane-anchored TWEAK can function as a juxtacrine signaling molecule and activate the NF-κB pathway,” Journal of Biological Chemistry, vol. 285, no. 23, pp. 17432–17441, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Kumar, D. Y. Makonchuk, H. Li, A. Mittal, and A. Kumar, “TNF-like weak inducer of apoptosis (TWEAK) activates proinflammatory signaling pathways and gene expression through the activation of TGF-β-activated kinase 1,” Journal of Immunology, vol. 182, no. 4, pp. 2439–2448, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Li, A. Mittal, P. K. Paul et al., “Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-κB-inducing kinase and p38 mitogen-activated protein kinase: a potential role MMP-9 in myopathy,” Journal of Biological Chemistry, vol. 284, no. 7, pp. 4439–4450, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Mittal, S. Bhatnagar, A. Kumar, P. K. Paul, S. Kuang, and A. Kumar, “Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice,” American Journal of Pathology, vol. 177, no. 4, pp. 1732–1742, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. D. J. Ahern and F. M. Brennan, “The role of Natural Killer cells in the pathogenesis of rheumatoid arthritis: major contributors or essential homeostatic modulators?” Immunology Letters, vol. 136, no. 2, pp. 115–121, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Schwartz, T. Rubinstein, L. C. Burkly et al., “Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study,” Arthritis Research & Therapy, vol. 11, no. 5, p. R143, 2009. View at Google Scholar · View at Scopus
  46. B. Serafini, R. Magliozzi, B. Rosicarelli, R. Reynolds, T. S. Zheng, and F. Aloisi, “Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue injury,” Journal of Neuropathology and Experimental Neurology, vol. 67, no. 12, pp. 1137–1148, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. N. L. Tran, W. S. McDonough, B. A. Savitch et al., “Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-κB and correlate with poor patient outcome,” Cancer Research, vol. 66, no. 19, pp. 9535–9542, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. S. L. Y. Feng, Y. Guo, V. M. Factor et al., “The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas,” American Journal of Pathology, vol. 156, no. 4, pp. 1253–1261, 2000. View at Google Scholar · View at Scopus
  49. S. A. Williams, S. K. Martin, C. Vincent et al., “Circulating levels of TWEAK correlate with bone erosion in multiple myeloma patients,” British Journal of Haematology, vol. 150, no. 3, pp. 373–376, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. A. L. Willis, N. L. Tran, J. M. Chatigny et al., “The fibroblast growth factor-inducible 14 receptor is highly expressed in HER2-positive breast tumors and regulates breast cancer cell invasive capacity,” Molecular Cancer Research, vol. 6, no. 5, pp. 725–734, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. J. S. Michaelson and L. C. Burkly, “Therapeutic targeting of TWEAK/Fn14 in cancer: exploiting the intrinsic tumor cell killing capacity of the pathway,” Results and Problems in Cell Differentiation, vol. 49, pp. 145–160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. M. D. Sanchez-Nio, A. Benito-Martin, S. Gonalves et al., “TNF superfamily: a growing saga of kidney injury modulators,” Mediators of Inflammation, vol. 2010, Article ID 182958, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. M. I. Yilmaz, J. J. Carrero, A. Ortiz et al., “Soluble TWEAK plasma levels as a novel biomarker of endothelial function in patients with chronic kidney disease,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 11, pp. 1716–1723, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. Z. C. Liu, Q. L. Zhou, X. Z. Li et al., “Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus,” Cytokine, vol. 53, no. 3, pp. 295–300, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Kralisch, M. Ziegelmeier, A. Bachmann et al., “Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease,” Atherosclerosis, vol. 199, no. 2, pp. 440–444, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. B. Munoz-García, J. L. Martín-Ventura, E. Martínez et al., “Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: modulation by atorvastatin,” Stroke, vol. 37, no. 8, pp. 2044–2053, 2006. View at Publisher · View at Google Scholar
  57. L. M. Blanco-Colio, J. L. Martin-Ventura, J. J. Carrero et al., “Vascular proteomics and the discovery process of clinical biomarkers: the case of TWEAK,” Proteomics-Clinical Applications, vol. 5, no. 5-6, pp. 281–288, 2011. View at Publisher · View at Google Scholar
  58. E. Chorianopoulos, M. Rosenberg, C. Zugck, J. Wolf, H. A. Katus, and N. Frey, “Decreased soluble TWEAK levels predict an adverse prognosis in patients with chronic stable heart failure,” European Journal of Heart Failure, vol. 11, no. 11, pp. 1050–1056, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Filusch, T. Zelniker, C. Baumgartner et al., “Soluble TWEAK predicts hemodynamic impairment and functional capacity in patients with pulmonary arterial hypertension,” Clinical Research in Cardiology, vol. 100, no. 10, pp. 879–885, 2011. View at Publisher · View at Google Scholar
  60. N. Ledee, M. Petitbarat, M. Rahmati et al., “New pre-conception immune biomarkers for clinical practice: interleukin-18, interleukin-15 and TWEAK on the endometrial side, G-CSF on the follicular side,” Journal of Reproductive Immunology, vol. 88, no. 2, pp. 118–123, 2011. View at Publisher · View at Google Scholar
  61. J. L. Martin-Ventura, J. S. Lindholt, J. A. Moreno et al., “Soluble TWEAK plasma levels predict expansion of human abdominal aortic aneurysms,” Atherosclerosis, vol. 214, no. 2, pp. 486–489, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. M. P. van Iersel, T. Kelder, A. R. Pico et al., “Presenting and exploring biological pathways with PathVisio,” BMC Bioinformatics, vol. 9, article no. 399, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. V. Nanjappa, R. Raju, B. Murthusamy, J. Sharma et al., “A comprehensive curated reaction map of leptin signaling pathway,” Journal of Proteomics & Bioinformatics, vol. 4, pp. 184–189, 2011. View at Google Scholar
  64. R. Raju, L. Balakrishnan, V. Nanjappa et al., “A comprehensive manually curated reaction map of rankl/rank-signaling pathway,” Database (Oxford), vol. 2011, Article ID bar021, 2011. View at Publisher · View at Google Scholar
  65. D. Telikicherla, A. Ambekar, S. Palapetta et al., “A comprehensive curated resource for follicle stimulating hormone signaling,” BMC Research Notes, vol. 4, p. 408, 2011. View at Publisher · View at Google Scholar
  66. R. Raju, V. Nanjappa, L. Balakrishnan et al., “NetSlim: high-confidence curated signaling maps,” Database, vol. 2011, Article ID bar032, 2011. View at Google Scholar
  67. K. Kandasamy, S. Sujatha Mohan, R. Raju et al., “NetPath: a public resource of curated signal transduction pathways,” Genome Biology, vol. 11, no. 1, p. r3, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. K. Kandasamy, S. Keerthikumar, R. Raju et al., “PathBuilder-open source software for annotating and developing pathway resources,” Bioinformatics, vol. 25, no. 21, pp. 2860–2862, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. Y. Hosokawa, I. Hosokawa, K. Ozaki, H. Nakae, and T. Matsuo, “Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts,” Clinical and Experimental Immunology, vol. 146, no. 3, pp. 540–549, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Wako, T. Ohba, T. Ando et al., “Mechanism of signal transduction in tumor necrosis factor-like weak inducer of apoptosis-induced matrix degradation by MMP-3 upregulation in disc tissues,” Spine, vol. 33, no. 23, pp. 2489–2494, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. R. Feltham, M. Moulin, J. E. Vince et al., “Tumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires cIAP1 RING dimerization and E2 binding,” Journal of Biological Chemistry, vol. 285, no. 23, pp. 17525–17536, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. H. Maecker, E. Varfolomeev, F. Kischkel et al., “TWEAK attenuates the transition from innate to adaptive immunity,” Cell, vol. 123, no. 5, pp. 931–944, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. E. Demir, S. Paley, K. Fukuda et al., “Erratum: the BioPAX community standard for pathway data sharing (Nat. Biotechnol. (2010) 28 (935-942),” Nature Biotechnology, vol. 28, no. 12, p. 1308, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Hucka, A. Finney, H. M. Sauro et al., “The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models,” Bioinformatics, vol. 19, no. 4, pp. 524–531, 2003. View at Publisher · View at Google Scholar · View at Scopus
  75. S. Kerrien, S. Orchard, L. Montecchi-Palazzi et al., “Broadening the horizon-level 2.5 of the HUPO-PSI format for molecular interactions,” BMC Biology, vol. 5, article no. 44, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. L. Xia, H. Shen, J. Lu, and W. Xiao, “TRAF2 and cIAP2 involve in TWEAK-induced MMP-9 production in fibroblast-like synoviocytes,” Rheumatology International, vol. 32, no. 1, pp. 281–282, 2012. View at Publisher · View at Google Scholar